Literature DB >> 2643868

Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients.

J F Cooper1, M J Lichtenstein, B S Graham, W Schaffner.   

Abstract

PURPOSE: Infections due to Mycobacterium chelonae are uncommon. Several renal transplant recipients at our medical center have developed M. chelonae infections during the past several years, so we decided to review our recent experience with M. chelonae infections. PATIENTS AND METHODS: The clinical microbiology laboratory records of four Vanderbilt University Affiliated Hospitals were reviewed. Ten patients with M. chelonae tissue or blood infections were identified between 1982 and July 1988.
RESULTS: All infections involved the skin and subcutaneous tissue. Three infections developed at the sites of medical injections. The remaining seven infections occurred in renal transplant recipients and produced a clinically distinctive syndrome. All were indolent tender nodular lesions on the extremities, usually the lower legs. Systemic symptoms were absent, and white blood cell counts were within normal limits. Diagnosis required tissue biopsy and cultures that were incubated for a month. Therapy consisted of surgical excision combined with long-term antibiotics. Even so, some patients had a chronic, relapsing course.
CONCLUSION: Although other diagnoses must be considered, the presumptive diagnosis of M. chelonae infection is suggested by the appearance of nodular erythematous lesions on the legs of a renal transplant recipient.

Entities:  

Mesh:

Year:  1989        PMID: 2643868     DOI: 10.1016/0002-9343(89)90264-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  An unusual surgical site infection in a liver transplant recipient.

Authors:  Vidhyachandra Gandhi; Aabha Nagral; Sanjay Nagral; Suryasnata Das; Camilla Rodrigues
Journal:  BMJ Case Rep       Date:  2010-09-29

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 4.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Recurrent catheter-related infection caused by a single clone of Mycobacterium chelonae with two colonial morphotypes.

Authors:  P R Hsueh; L J Teng; P C Yang; Y C Chen; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Disseminated Mycobacterium chelonae infection presenting as progressive multifocal osteomyelitis: Report of two cases and a review of the literature.

Authors:  D A Oelberg; J Mendelson; M A Miller; A Dascal
Journal:  Can J Infect Dis       Date:  1994-01

7.  Iatrogenic outbreak of M. chelonae skin abscesses.

Authors:  D Camargo; C Saad; F Ruiz; M E Ramirez; M Lineros; G Rodriguez; E Navarro; B Pulido; L C Orozco
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

8.  Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.

Authors:  B M Knoll
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

9.  Mycobacterium chelonei infection of a Broviac catheter insertion site.

Authors:  H D Engler; A Hass; D S Hodes; E J Bottone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

Review 10.  Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria.

Authors:  R J Kothavade; R S Dhurat; S N Mishra; U R Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.